Bristol-Myers Positive, Cooper Jumps, WBD Declines - podcast episode cover

Bristol-Myers Positive, Cooper Jumps, WBD Declines

Nov 24, 20254 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description


Bristol-Myers (BMY)

  • Analysts are citing a positive readacross to Bristol-Myers from positive results for Bayer's experimental stroke-prevention drug
  • Cantor: Bayer’s data supports confidence in BMY’s own program in secondary stroke prevention
  • Earlier this month:  shares fell after one of its most important experimental medicines appeared unlikely to benefit patients who had suffered a heart complication, another setback for the drugmaker’s product pipeline


Cooper (COO)

  • Maker of medical devices and surgical instruments;
  • Activist investors Browning West wrote a letter to the board saying its “inadequate” oversight has led the company to significantly underperform and miss financial guidance
  • Calls for urgent change at the Board to refocus the co. and appoint Browning West’s director candidates
  • Urges Cooper to pause any potential restructuring efforts until Browning West’s recommended directors are seated so that any restructuring is optimized in scope and magnitude
  • Reuters reported earlier this month that Browning West owns about 4% of Cooper


WBD

  • Netflix, Comcast and Paramount Skydance all submitted bids for Warner Bros. Discovery by the Nov. 20 deadline for a first bid
  • Comcast and Netflix are most interested in the film and TV library; Paramount is willing to buy the whole company
  • Fourth owner in seven years
  • Warner Bros. may not reach a deal with any of the suitors and may continue its current plan to separate its flagging cable networks from the rest of the businesses next year

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, podcasts, radio news, The.

Speaker 2

Stock Movers Report, your roundup of companies making moves in the stock market harnessing the power of Bloomberg data.

Speaker 3

It's called the flu Paul Sweeney live here on a Bloomberg Interactive Broker studio, streaming live on YouTube as well. Boy Green on the screen. That's for sure. Let's take a look at some of the stocks on the move today. We're joined by Bloomberg Christina, you know, Christine, what are you looking at?

Speaker 1

Well, Paull, it's not just tech that is leading this rally today. We have a rally in a lot of other companies as well, including Bristol Myers so ticker bmy Those shares are up more than four percent at the moment. So interestingly, it's actually benefiting not necessarily from its own news, but because of news from it's a competitor, Bear, but

has positive read across for this company. So Bear's experimental stroke prevention drug saw some positive results in counter Fitzgerald analyst saying that Bear's data supports confidence and bmise oh in the program in secondary stroke prevention, and so very interesting, especially because in the context of earlier declines earlier this month because bmwy's most important experimental medicines appeared unlikely to benefit patients who suffered a hard complication. So that was

a setback earlier this month. But now looks like they're benefiting from this positive results from Bears, a stroke prevention drug. So there you go, all.

Speaker 2

Right, good stuff. Second stock you're watching.

Speaker 1

We're looking at Cooper Companies today, So took her COO. Those shares up just slightly h four tens of one percent now, So Cooper Companies, it's a maker of medical devices and surgical instruments, is getting a little bit of activist action, actually, so investors. Branding West writing a letter to its board saying that it's quote inadequate oversight, has a lot of company to significantly underperform a mis financial guidance.

So apparently Branding West is recommending director candidates and is urging the company need to pause any restructuring effort. So clearly maybe something that could be weighing on a stock today. That's why it's not rallying as much as the rest of the complex.

Speaker 3

All right, one more Warner Brothers, Discovery, Wonder Brothers, any news.

Speaker 1

Hit, well, no news yet. The news is that there's no news is evidently weighing on the stock today, so ticker WVD those airs are down one point six percent. We did get bids from Netflix, Comcast, Paramounts, Guide Dance, all within the November twentieth deadline, but now investors are really just wondering when are we get going to get the news, because if they don't reach a deal, then they just might just continue. It's their plan to separate

their cable networks from the rest of the businesses. They're hoping to make a decision by Christmas, but doesn't seem like, you know, we're getting anywhere close. I mean, the bids are interesting, right, so Comcasts in Netflix primarily interested in the film and TV library, and Paramount is willing to

buy the entire company. But I think the uncertainty just really comes from the fact that this is potentially going to be it's for owner in seven years, and so you can imagine investors not really liking the lack of certainty around its ownership moving forward.

Speaker 2

The Stockmover's report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android